Compassionate Use Program for Olipudase Alfa Enzyme Replacement Therapy for Patients With Chronic Acid Sphingomyelinase Deficiency (ASMD)
Clinical trial NCT04877132 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04877132
- Sponsor
- Sanofi
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.